HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 207 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $262,000 | -9.7% | 16,900 | 0.0% | 0.02% | +25.0% |
| Q2 2019 | $290,000 | +6.6% | 16,900 | 0.0% | 0.02% | -4.8% |
| Q1 2019 | $272,000 | -55.4% | 16,900 | -59.5% | 0.02% | -57.1% |
| Q4 2018 | $610,000 | -36.7% | 41,687 | -21.4% | 0.05% | +133.3% |
| Q3 2018 | $964,000 | -43.4% | 53,031 | -47.5% | 0.02% | -34.4% |
| Q2 2018 | $1,703,000 | +252.6% | 100,933 | +309.3% | 0.03% | +255.6% |
| Q1 2018 | $483,000 | +403.1% | 24,662 | +418.4% | 0.01% | +350.0% |
| Q4 2017 | $96,000 | – | 4,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |